AstraZeneca’s Vaccine Does Not Work Well Against Virus Variant in South Africa
The bad news, coming nearly a week after a million doses of the AstraZeneca-Oxford vaccine arrived in South Africa, was a big setback for the country.
View original article
Contributor: Benjamin Mueller, Rebecca Robbins and Lynsey Chutel
